Fig 1: Neutrophil function in MM and MGUS high-density neutrophils is impaired as consequence of a MM-related soluble factors. (A) Gene set enrichment analysis of MM versus healthy HDNs identified an impairment in the FC-γ-receptor I (CD64) mediated phagocytosis. The green curves show the enrichment score and reflects the degree to which each gene (black vertical lines) is represented at the bottom of the ranked gene list. The heat map indicates the relative abundance (red to blue) of the genes specifically enriched in MM-HDNs as compared with the control cells. To validate the GEP findings, in an independent set of HDNs at steady state, as obtained from peripheral blood of MM, MGUS and healthy subjects, median intensity of fluorescence (MFI) of FC-γ-receptors CD64 (B-C) and CD16 (D) was detected by flow cytometry. (E-H) After exposure of healthy HDNs to MM conditioned media obtained from two human myeloma cell lines U266 and OPM2 or 500 ng/mL IL6 for 24 hours, CD64, p-STAT3, STAT5a and CD16 were measured by flow cytometry. (I-N) In the same experiments, the response to LPS was also evaluated. For more robust statistical evaluation, MFI values were converted to a resolution metric, such as the RD defined as (Mediantreatment − Mediancontrol)/(rSDtreatment + rSDcontrol) to further perform t-test to compare results of different experiments and runs. Stars denote p-value (***p < 0.0001) using t-test. After exposure to E-coli bacteria opsonized with IgG and complement of pooled sera, percentage of phagocytic activity (D) and oxidative burst (E) were detected by flow cytometry in controlled conditions in healthy (grey bars), MGUS (blue bars) and MM (red bars) HDNs. Stars denote p-value (*p < 0.005, **p < 0.001, ***p < 0.0001) using t-test for direct-pairwise comparison or ANOVA among three groups.
Fig 2: Arginase-1, target of activated STAT3, is increased in MM and MGUS high-density neutrophils. The association between the quantity of ARG1 transcript in MM and MGUS high-density neutrophils with STAT1 (A) and STAT3 (B) transcripts is shown. Dot-lines represent interval of confidence. (C) Arginase expression in healthy, MGUS and MM high-density neutrophils, as detected by qRT-PCR is shown; the differences were evaluated according to ANOVA test. In an independent set of HDNs at steady state, as obtained from peripheral blood of MM, MGUS and healthy subjects, median intensity of fluorescence (MFI) of ARG1 was detected by flow cytometry(D-E). (F-H) ARG1 immunofluorescence staining in HDN isolated by immune-magnetic-based positive selection after density gradient sedimentation from healthy, MGUS and MM subjects. ARG-1 localized in cytosol, in grains larger in MM-HDN than in controls. (I) After exposure of healthy HDNs to MM conditioned media obtained from two human myeloma cell lines U266 and OPM2 or 20 ng/mL IL6 or 100 ng/mL LPS for 24 hours, ARG1 was measured by flow cytometry. For more robust statistical evaluation, MFI values were converted to a resolution metric, such as the RD defined as (Mediantreatment-Mediancontrol)/(rSDtreatment + rSDcontrol) to further perform t-test to compare results of different experiments and runs. Stars denote p-value (***p < 0.0001) using t-test.
Supplier Page from BioLegend for Recombinant Human IL-6 (Animal-Free)